# Alleviant ALLAY-HF Study

> **NCT05685303** · NA · ENROLLING_BY_INVITATION · sponsor: **Alleviant Medical, Inc.** · enrollment: 700 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Alleviant ALV1 System
- **OTHER:** Sham-Control

## Key facts

- **NCT ID:** NCT05685303
- **Lead sponsor:** Alleviant Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-01-10
- **Primary completion:** 2027-12-01
- **Final completion:** 2032-12-01
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05685303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05685303, "Alleviant ALLAY-HF Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05685303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*